182 related articles for article (PubMed ID: 24939653)
1. A numerical method for analysis of in vitro time-dependent inhibition data. Part 2. Application to experimental data.
Korzekwa K; Tweedie D; Argikar UA; Whitcher-Johnstone A; Bell L; Bickford S; Nagar S
Drug Metab Dispos; 2014 Sep; 42(9):1587-95. PubMed ID: 24939653
[TBL] [Abstract][Full Text] [Related]
2. A numerical method for analysis of in vitro time-dependent inhibition data. Part 1. Theoretical considerations.
Nagar S; Jones JP; Korzekwa K
Drug Metab Dispos; 2014 Sep; 42(9):1575-86. PubMed ID: 24939654
[TBL] [Abstract][Full Text] [Related]
3. Time-dependent enzyme inactivation: Numerical analyses of in vitro data and prediction of drug-drug interactions.
Yadav J; Paragas E; Korzekwa K; Nagar S
Pharmacol Ther; 2020 Feb; 206():107449. PubMed ID: 31836452
[TBL] [Abstract][Full Text] [Related]
4. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
[TBL] [Abstract][Full Text] [Related]
5. Improved Predictions of Drug-Drug Interactions Mediated by Time-Dependent Inhibition of CYP3A.
Yadav J; Korzekwa K; Nagar S
Mol Pharm; 2018 May; 15(5):1979-1995. PubMed ID: 29608318
[TBL] [Abstract][Full Text] [Related]
6. Statistical methods for analysis of time-dependent inhibition of cytochrome p450 enzymes.
Yates P; Eng H; Di L; Obach RS
Drug Metab Dispos; 2012 Dec; 40(12):2289-96. PubMed ID: 22942318
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Assessment of Potential for CYP-Inhibition-Based Drug-Drug Interaction Between Vonoprazan and Clopidogrel.
Nishihara M; Yamasaki H; Czerniak R; Jenkins H
Eur J Drug Metab Pharmacokinet; 2019 Apr; 44(2):217-227. PubMed ID: 30361928
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of an in vitro, seven-in-one human cytochrome P450 assay for evaluation of both direct and time-dependent inhibition.
Dahlinger D; Duechting S; Nuecken D; Sydow K; Fuhr U; Frechen S
J Pharmacol Toxicol Methods; 2016; 77():66-75. PubMed ID: 26528794
[TBL] [Abstract][Full Text] [Related]
9. Cocktail-substrate approach-based high-throughput assay for evaluation of direct and time-dependent inhibition of multiple cytochrome P450 isoforms.
Kozakai K; Yamada Y; Oshikata M; Kawase T; Suzuki E; Haramaki Y; Taniguchi H
Drug Metab Pharmacokinet; 2014; 29(2):198-207. PubMed ID: 24172718
[TBL] [Abstract][Full Text] [Related]
10. P450-Based Drug-Drug Interactions of Amiodarone and its Metabolites: Diversity of Inhibitory Mechanisms.
McDonald MG; Au NT; Rettie AE
Drug Metab Dispos; 2015 Nov; 43(11):1661-9. PubMed ID: 26296708
[TBL] [Abstract][Full Text] [Related]
11. In vitro oxidative metabolism of cajaninstilbene Acid by human liver microsomes and hepatocytes: involvement of cytochrome p450 reaction phenotyping, inhibition, and induction studies.
Hua X; Peng X; Tan S; Li C; Wang W; Luo M; Fu Y; Zu Y; Smyth H
J Agric Food Chem; 2014 Oct; 62(43):10604-14. PubMed ID: 25272989
[TBL] [Abstract][Full Text] [Related]
12. Modelling atypical CYP3A4 kinetics: principles and pragmatism.
Houston JB; Galetin A
Arch Biochem Biophys; 2005 Jan; 433(2):351-60. PubMed ID: 15581591
[TBL] [Abstract][Full Text] [Related]
13. Impact of Lipid Partitioning on the Design, Analysis, and Interpretation of Microsomal Time-Dependent Inactivation.
Yadav J; Korzekwa K; Nagar S
Drug Metab Dispos; 2019 Jul; 47(7):732-742. PubMed ID: 31043439
[TBL] [Abstract][Full Text] [Related]
14. Numerical analysis of time-dependent inhibition kinetics: comparison between rat liver microsomes and rat hepatocyte data for mechanistic model fitting.
Pham C; Nagar S; Korzekwa K
Xenobiotica; 2020 Nov; 50(11):1301-1310. PubMed ID: 28644704
[TBL] [Abstract][Full Text] [Related]
15. Enzyme kinetic modelling as a tool to analyse the behaviour of cytochrome P450 catalysed reactions: application to amitriptyline N-demethylation.
Schmider J; Greenblatt DJ; Harmatz JS; Shader RI
Br J Clin Pharmacol; 1996 Jun; 41(6):593-604. PubMed ID: 8799527
[TBL] [Abstract][Full Text] [Related]
16. An automated cocktail method for in vitro assessment of direct and time-dependent inhibition of nine major cytochrome P450 enzymes - application to establishing CYP2C8 inhibitor selectivity.
Kahma H; Aurinsalo L; Neuvonen M; Katajamäki J; Paludetto MN; Viinamäki J; Launiainen T; Filppula AM; Tornio A; Niemi M; Backman JT
Eur J Pharm Sci; 2021 Jul; 162():105810. PubMed ID: 33753217
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective inhibition of CYP2C19 and CYP3A4 by fluoxetine and its metabolite: implications for risk assessment of multiple time-dependent inhibitor systems.
Lutz JD; VandenBrink BM; Babu KN; Nelson WL; Kunze KL; Isoherranen N
Drug Metab Dispos; 2013 Dec; 41(12):2056-65. PubMed ID: 23785064
[TBL] [Abstract][Full Text] [Related]
18. Dynamic and Static Simulations of Fluvoxamine-Perpetrated Drug-Drug Interactions Using Multiple Cytochrome P450 Inhibition Modeling, and Determination of Perpetrator-Specific CYP Isoform Inhibition Constants and Fractional CYP Isoform Contributions to Victim Clearance.
Iga K
J Pharm Sci; 2016 Mar; 105(3):1307-17. PubMed ID: 26886336
[TBL] [Abstract][Full Text] [Related]
19. Atypical Michaelis-Menten kinetics in cytochrome P450 enzymes: A focus on substrate inhibition.
Leow JWH; Chan ECY
Biochem Pharmacol; 2019 Nov; 169():113615. PubMed ID: 31445022
[TBL] [Abstract][Full Text] [Related]
20. Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamily.
Gorski JC; Jones DR; Wrighton SA; Hall SD
Biochem Pharmacol; 1994 Jul; 48(1):173-82. PubMed ID: 8043020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
